trimebutine has been researched along with Chronic Disease in 4 studies
Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind crossover study on the effects of trimebutine on large bowel function was performed in 24 consecutive patients complaining of chronic idiopathic constipation." | 9.07 | Effects of trimebutine on colonic function in patients with chronic idiopathic constipation: evidence for the need of a physiologic rather than clinical selection. ( Devroede, G; Pilote, M; Schang, JC, 1993) |
| "A double-blind crossover study on the effects of trimebutine on large bowel function was performed in 24 consecutive patients complaining of chronic idiopathic constipation." | 5.07 | Effects of trimebutine on colonic function in patients with chronic idiopathic constipation: evidence for the need of a physiologic rather than clinical selection. ( Devroede, G; Pilote, M; Schang, JC, 1993) |
| "Of 86 cases of aged patients with chronic gastritis treated with Trimebutine or Flutazolam, we evaluated the changes of serum pepsinogen-I and gastrin levels in their clinical courses from the points of the correlation with severity of chronic gastritis, aging phenomenon and the changes of symptom and endoscopic findings." | 3.67 | [Studies on the clinical significance concerning the changes in serum pepsinogen-I and gastrin levels in aged patients with chronic gastritis]. ( Asaka, M; Hamada, Y; Kamiya, K; Kamiya, T; Koyama, M; Matsushima, T; Myazaki, T, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schang, JC | 1 |
| Devroede, G | 1 |
| Pilote, M | 1 |
| Matsue, T | 1 |
| Yamato, S | 1 |
| Umeda, N | 1 |
| Hamada, Y | 1 |
| Kamiya, K | 1 |
| Koyama, M | 1 |
| Asaka, M | 1 |
| Matsushima, T | 1 |
| Myazaki, T | 1 |
| Kamiya, T | 1 |
| Camarri, E | 1 |
2 trials available for trimebutine and Chronic Disease
| Article | Year |
|---|---|
Effects of trimebutine on colonic function in patients with chronic idiopathic constipation: evidence for the need of a physiologic rather than clinical selection.
Topics: Action Potentials; Adolescent; Adult; Aged; Chronic Disease; Colon; Constipation; Defecation; Double | 1993 |
Fenoverine: smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation.
Topics: Adult; Aged; Benzoates; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Gast | 1986 |
2 other studies available for trimebutine and Chronic Disease
| Article | Year |
|---|---|
[Mechanism of action of trimebutine maleate on gastro-colic reflex in patients with irritable bowel syndrome].
Topics: Abdominal Pain; Adult; Animals; Chronic Disease; Colon; Colonic Diseases, Functional; Female; Humans | 1990 |
[Studies on the clinical significance concerning the changes in serum pepsinogen-I and gastrin levels in aged patients with chronic gastritis].
Topics: Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Chronic Disease; Female; Gastrins; Ga | 1988 |